High Risk: The Debate Over the Price of Specialty Drugs and Zika Virus
22 September 2016
Dr. Scott Gottlieb, Resident Fellow at the American Enterprise Institute, discusses the history and regulations surrounding drug prices, who should finance important medical advancements, and the continuing Zika threat.
0:00 0:00

Related Podcasts

Price Controls, Single-Payer Systems and Other Disastrous Healthcare Ideas
04 April 2025
Sally Pipes, President and CEO of Pacific Research Institute, discusses her recently released book, “The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy and How to Keep It,” the horrible impacts of price controls, how single-payer healthcare systems fail children and cancer patients, and more.
Presidential Debate: Game Changer or Channel Changer?
13 September 2024
In an interview with CFIF, William Conti, an attorney in Washington, D.C., discusses the first debate between former President Trump and Vice President Harris, the impact of endorsements, the status of the fight for the Senate in 2024, and the Republican bench looking forward to 2028.
The Negative Consequences of Drug Price Controls for Patients
02 September 2024
Sally Pipes, Founder and President of Pacific Research Institute, discusses the impact of drug price controls under the Inflation Reduction Act (IRA), what it means for research and development of life-saving medicines, and how the IRA's drug pricing provisions will reduce access to new cures and treatments and result in longer wait times for existing medicines.
Government Price Controls for Prescription Drugs Are Bad Medicine for Americans
28 June 2024
Sally Pipes, President and CEO of Pacific Research Institute, discusses how President Biden's price controls will result in prescription drug shortages and discourage innovation, how government mandates and regulations raise insurance costs, and the grim prognosis on Medicare and Medicaid's viability.
Election 2024: Breaking Down Some of the High Stakes Races
03 May 2024
William J. Conti, an Attorney from Washington, DC, discusses some of the U.S. Senate races to watch this year, the impact voter turnout for the presidential race may have on the Congressional races, and what Robert F. Kennedy, Jr.'s presidential run might mean for the other candidates.
Beware Price Controls for Prescription Drugs
11 January 2019
Pat Rosenstiel, Founder and Chairman of the Trade Alliance to Promote Prosperity, discusses HHS's proposal to create an "International Pricing Index" payment model for prescription drugs administered under Medicare Part B, why this proposal is bad for Americans and how it will hurt research and development of new drugs.